Comments

Palvella Therapeutics Stock News

PVLANASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$97.75
8.779.86%
Last update: Dec 16, 2:35 PM
Why is it moving?
Palvella: 73% Improved In Phase 2 Study Of Skin Condition Treatment
Overview

News

EarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report

Latest Palvella Therapeutics Stock News | NASDAQ:PVLA | Benzinga

Get the latest news on Palvella Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Palvella Therapeutics performance

People Also Watch

ARS Pharmaceuticals Inc
NASDAQ:SPRY
$10.63
0.38%
MoonLake Immunotherapeutics
NASDAQ:MLTX
$14.92
4.19%
CureVac NV
NASDAQ:CVAC
$4.78
-4.40%
CareDx Inc
NASDAQ:CDNA
$19.37
-2.71%
Xencor Inc
NASDAQ:XNCR
$16.77
-0.15%
Pharming Group
NASDAQ:PHAR
$16.29
0.06%
YD Bio Ltd
NASDAQ:YDES
$12.96
4.08%
Tyra Biosciences Inc
NASDAQ:TYRA
$22.92
3.62%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved